For consulting in pharmaceutical development, please feel free to contact us!
Ohsugi BioPharma Consulting Co., Ltd. is a company primarily engaged in pharmaceutical development support services. We provide consulting services in five areas: drug discovery research, CMC development, regenerative medicine, clinical development, and business development, with consultants who are well-versed in the fundamental research of biopharmaceuticals and the CMC development/quality assurance of both low molecular weight drugs and biopharmaceuticals/regenerative medicine products, supporting the global development of pharmaceuticals. In addition to this business, we also conduct seminar services and paper writing services. [Business Activities] ■ Pharmaceutical Development Support Services ■ Seminar Services ■ Paper Writing Services *For more details, please refer to our catalog or feel free to contact us.
Inquire About This Product
basic information
【Business Activities】 ■ Pharmaceutical Development Support Business ■ Recruitment Business ■ Seminar Business ■ Human Resources Consulting Business ■ English Training and English Composition Business ■ Overseas Business *For more details, please refer to the catalog or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the catalog or feel free to contact us.
catalog(1)
Download All CatalogsCompany information
Ohsugi BioPharma Consulting Co., Ltd. develops its business primarily in three areas: pharmaceutical development support, seminar services, and manuscript preparation services. Our team consists of experts with leadership experience and successful backgrounds in various sectors, including CMC for the commercialization of biopharmaceuticals, global clinical development, and regulatory affairs. We are confident that we can provide appropriate advice to those aiming for innovative biopharmaceutical research and development. Our company conducts qualified situational assessments based on specialized experience regarding our clients' pharmaceuticals and promptly proposes appropriate milestones and action plans based on risk assessments, thereby supporting our clients in achieving their goals in line with their needs or development strategies.